Zyfuro 250 Tablet contains Cefuroxime 250mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of gram-positive and gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea. Cefuroxime exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Zyfuro 250 is well absorbed orally, achieving therapeutic plasma concentrations that facilitate effective eradication of susceptible pathogens. The dosage and duration of treatment should be tailored according to the severity and type of infection, as well as patient-specific factors such as renal function. Common adverse effects may include gastrointestinal disturbances like nausea, diarrhea, and abdominal pain, while hypersensitivity reactions, although rare, can occur in patients with a history of beta-lactam allergy. Caution is advised in patients with renal impairment, and concurrent use with other nephrotoxic drugs should be monitored closely. Zyfuro 250 Tablet should be used strictly under medical supervision to ensure appropriate use and to minimize the risk of antibiotic resistance.